Top Markets
#1 Siacoin Siacoin +27.05%
#2 DogBull DogBull +26.93%
#3 Merlin's Seal BTC Merlin's Seal BTC +25.80%
#4 Cash Cat Cash Cat +23.26%
#5 MarsCoin MarsCoin +10.63%
#6 Akedo Akedo +9.83%
#7 The Bitcoin Bull The Bitcoin Bull +9.42%
#8 Pons Pons +9.24%
#9 Bitway Bitway +8.53%
#10 Asteroid Shiba Asteroid Shiba +8.32%
Coin of the day
Siacoin Siacoin
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENC
Hisse Senetlerindeki Sıralama #14221
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading... Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
Hisse Fiyatı
$12.33
Son senkronizasyon: 2026-08-31
Piyasa Değeri
$428.31M
Değişim (1 gün)
0.49%
Değişim (1 yıl)
39.01%
Ülke
US
Ticaret Fennec Pharmaceuticals Inc. (FENC)

Kategori

Healthcare
Fennec Pharmaceuticals Inc. (FENC) için kazanç
2026 itibarıyla kazanç TTM: 0
Fennec Pharmaceuticals Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Fennec Pharmaceuticals Inc. için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH